Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant chimeric monoclonal antibody against CD20

EU orphan designation number: EU/3/09/699   
Active ingredient: Recombinant chimeric monoclonal antibody against CD20
Indication: Treatment of chronic lymphocytic leukaemia
Sponsor: LFB-Biotechnologies
3 avenue des Tropiques BP 50052, Les Ulis, 91942 Courtaboeuf CEDEX, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/12/2009 Orphan designation EMEA/OD/090/09 (2009)9603 of 26/11/2009
22/06/2010 Change of name and/or address of sponsor EMEA/OD/090/09